The potential genetic association between RETNLB and CDI as well as the functional work showing the role of RELM-Beta in protecting against enteric infections suggests that RELM-Beta should be investigated further in the pathogenesis of CDI and may represent a novel therapeutic target. This evidence concerns the gene RETNLB and clostridium difficile infection.